DXR
Daxor Corporation
NASDAQ: DXR · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$8.78
-2.12% today
Updated 2026-10-29
Market cap
$56.92M
P/E ratio
8.95
P/S ratio
1,815.14x
EPS (TTM)
$1.09
Dividend yield
—
52W range
$9 – $15
Volume
0.0M
Daxor Corporation (DXR) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$8.78
12-Month target
$12.61
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 8.95x (capped 25x) · Margin: 19,861.00%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.